SEC Filing Summary: Ra Medical Systems, Inc. (RMED)
Business Context and Reporting Period
This Form 8-K was filed by Ra Medical Systems, Inc. (not Catheter Precision, Inc.) on December 17, 2020. The report addresses a corporate action regarding the listing status of the company's common stock.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event notification and does not contain financial statement data.
Material Changes
- Delisting and Relisting: The Company received approval to list its Common Stock on the NYSE American.
- Notice to NYSE: Written notice was provided to the New York Stock Exchange (NYSE) to delist the securities from that exchange.
- Trading Transition:
- Trading on the NYSE will conclude at the close of business on December 21, 2020.
- Trading on the NYSE American is anticipated to commence on December 22, 2020.
- The stock symbol will remain RMED.
Guidance, Outlook, and Risks
The filing does not contain management commentary on financial guidance, future outlook, or specific risk factors beyond the operational change of the listing venue. The primary contingency noted is the successful transition of trading between exchanges on the specified dates.
Investor Verification Checklist
- Confirm the stock symbol RMED remains unchanged during the transition.
- Verify the exact trading halt time on the NYSE on December 21, 2020.
- Confirm the opening time for trading on the NYSE American on December 22, 2020.
- Review the attached press release (Exhibit 99.1) for additional context on the reasons for the exchange transfer.